April 21, 2008 - Angiotech Pharmaceuticals Inc. said last week it received 510(k) clearance from the FDA to market its 5 ...
April 21, 2008 - The first patients were treated in a U.S. feasibility study using the Edwards Lifesciences SAPIEN ...
April 16, 2008 - Boston Scientific Corp. will acquire CryoCor, Inc. and pay a cash purchase price of $1.35 per share of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
ViTALConnect software is a Web-enabled medical tool that allows physicians to use PCs or notebook computers to access interactive 2D, 3D and 4D advanced visualization. ViTALConnect software offers users access that is critical in today’s hospital environment. This solution enables users to review studies and perform advanced analysis from any where at any time.
April 18, 2008 - Boston Scientific Corpo. has received approval for the sale of its TAXUS Liberte paclitaxel-eluting ...
Medtronic's Talent Abdominal Stent Graft is FDA cleared for use on the CoilTrac Delivery System, a medical device that ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 17, 2008 - Medtronic Inc. received clearance from the FDA for use of the Talent Abdominal Stent Graft on the CoilTrac Delivery System, a medical device that expands patient access to a minimally-invasive treatment option for abdominal aortic aneurysms.
April 16, 2008 - In a recent study conducted by Lund University Hospital, Sweden, the effect of induced hypothermia ...
Smiths Medical offers the Level 1 ConductiTherm Warming System with built-in pressure relief designed for positioning ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 15, 2008 – The American College of Cardiology, American College of Emergency Physicians and the Duke University ...
April 15, 2008 - Researchers at the University of North Carolina at Chapel Hill's School of Medicine have shown some heart cells in response to one signal will act, while others lie in wait, countering the belief that precursor cells all respond to the same cue before turning into the muscle tissue of this vital organ.
April 15, 2008 - Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital have begun the world's first clinical trial to treat heart attack patients with a special type of stem cell to promote better healing and to prevent congestive heart failure, which many patients develop following a heart attack.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 14 - Doctors implanted the ATS 3f Aortic Bioprosthesis, marking the first North American commercial implant after ...
April 14, 2008 - Boston Scientific Corp. reported that the Japanese Ministry of Health, Labor and Welfare (MHLW) ...
April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego.